McKesson completes divestiture of Canada-based Rexall, Well.ca
The transaction enables McKesson to focus capital deployment and prioritize investments in strategic oncology and biopharma growth platform.
McKesson shared that on Dec. 30, 2024, it closed the transaction announced in September 2024 to sell its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a Canadian private equity firm.
[Related: McKesson to sell Rexall, Well.ca to Birch Hill Equity Partners]
McKesson said this transaction enables the company to focus capital deployment and prioritize investments expanding its strategic oncology and biopharma growth platforms.